Abbott India
ABBOTINDIA · Pharma > Pharmaceuticals & Drugs · Chairman: Munir Shaikh Listing date: Jan. 9, 2010 · Employees: 3585 · Mumbai · http://www.abbott.co.in

Stock Price vs Company Growth
1d
0.8%
1w
1.0%
1m
3.3%
3m
3.3%
6m
14.3%
1y
18.5%
5y
29.9%
10y
32.4%
all
28.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 25,865 0.8%
25,200
29,628
Company Overview

Sales
5,753 Cr
Growth: 9.5%
Profit after Tax
1,146 Cr
Growth: 5.9%
Large Cap
54,961 Cr
P/E: 48.0x
Industry P/E: 35.5x
Fundamentals

Sales (Cr) ₹ 5,753
Growth 9.5%
EBITDA 24.4%
P/S 9.6x
Dividend 0.8%
P/E 48.0x
Book Value ₹ 1,931
PEG Ratio 5.1x
ROE 31.5%
P/B 13.4x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
1.64 %
Promoters
Abbott Capital India Limited
50.44 %
Abbott Healthcare Products Limited
17.62 %
British Colloids Limited
6.92 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.Products and Services offered by the companyCardiovascular- Keeping heart healthy with breakthrough medical technologies.Diabetes- Helping people with diabetes enjoy healthier, active lives.
Investors (50)
Followers (16)